SIGRID THERAPEUTICS Trademark

Trademark Overview


On Friday, January 19, 2024, a trademark application was filed for SIGRID THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SIGRID THERAPEUTICS trademark a serial number of 98365730. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, November 14, 2024. This trademark is owned by Sigrid Therapeutics AB. The SIGRID THERAPEUTICS trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Nutritional supplements; dietary supplements; dietary and nutritional supplements for the treatment and prevention of obesity and being overweight; dietary and nutritional supplements for boosting daily energy levels, balancing blood sugar, and maintaining healthy weight; dietary and nutritional supplements for the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol, LDL cholesterol levels and blood lipids; dietetic foods adapted for medical purposes; dietetic foods and beverages adapted for medical use; dietetic foods for the prevention and treatment of prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; dietetic foods for the treatment and prevention of obesity and being overweight; dietetic foods for the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol, LDL cholesterol levels and blood lipids; dietetic preparati...

Surgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweight, and for use in weight control; medical devices for the treatment and prevention of prediabetes, diabetes and glycemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; surgical and medical devices, capsulated devices and orally administered medical devices all ...

General Information


Serial Number98365730
Word MarkSIGRID THERAPEUTICS
Filing DateFriday, January 19, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, November 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2024

Trademark Statements


Goods and ServicesNutritional supplements; dietary supplements; dietary and nutritional supplements for the treatment and prevention of obesity and being overweight; dietary and nutritional supplements for boosting daily energy levels, balancing blood sugar, and maintaining healthy weight; dietary and nutritional supplements for the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol, LDL cholesterol levels and blood lipids; dietetic foods adapted for medical purposes; dietetic foods and beverages adapted for medical use; dietetic foods for the prevention and treatment of prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; dietetic foods for the treatment and prevention of obesity and being overweight; dietetic foods for the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol, LDL cholesterol levels and blood lipids; dietetic preparations adapted for medical use; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for medical use; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; health food supplements for persons with special dietary requirements; pharmaceuticals and natural remedy preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; preparations for use in naturopathy for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; chemical preparations for medical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemico- pharmaceutical preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; chemical preparations for pharmaceutical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances and dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances and dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients, and not including products primarily for use in the treatment of angina pectoris and high blood pressure
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesSurgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweight, and for use in weight control; medical devices for the treatment and prevention of prediabetes, diabetes and glycemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, January 19, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSigrid Therapeutics AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStockholm 11329
SE

Trademark Events


Event DateEvent Description
Friday, January 19, 2024NEW APPLICATION ENTERED
Saturday, May 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 15, 2024ASSIGNED TO EXAMINER
Wednesday, August 21, 2024NON-FINAL ACTION WRITTEN
Wednesday, August 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 21, 2024NON-FINAL ACTION E-MAILED